| Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome. | |
| | |
MedLine Citation:
|
PMID: 16871408 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hyperimmunoglobulinemia D/periodic fever syndrome is caused by recessively inherited mutations in the mevalonate kinase gene and is characterized by persistently high polyclonal serum IgD titre and recurrent febrile attacks. No conventional therapy exists for preventing the typical recurrent inflammatory picture of patients. A host of studies have evidenced that elevated levels of various cytokines, such as interleukin-1 (IL-1), mark febrile attacks in this disease and that IL-1 might represent a suitable therapeutic target. We describe the case of a 7-year-old female-child with an established diagnosis of hyperimmunoglobulinemia D/periodic fever syndrome in whom anakinra, IL-1 receptor antagonist, was daily administered at the dosage of 1 mg/kg/day by subcutaneous injection for 18 months after numerous disappointing attempts with non-steroidal anti-inflammatory drugs, steroids, colchicine and etanercept through the years. The clinical response under anakinra treatment was recorded through a standardized diary, whilst inflammation parameters were serially measured in comparison with the half-year before starting anakinra. Frequency and severity of fever attacks were totally reduced by anakinra and this is the first child demonstrating that symptoms of hyperimmunoglobulinemia D/periodic fever syndrome might be at least extenuated by anakinra, though not abolished. |
| | |
Authors:
|
Donato Rigante; Valentina Ansuini; Barbara Bertoni; Anna Lisa Pugliese; Laura Avallone; Gilda Federico; Achille Stabile |
Related Documents
:
|
15808678 - Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. 17089418 - Stability of alginate-polyornithine microcapsules is profoundly dependent on the site o... 1534058 - Promotion of pancreatic islet allograft survival by intrathymic transplantation of bone... 6789508 - A technique for transplanting pancreatic islets as a vascularized graft and prevention ... 1868498 - Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects. 9780338 - Treatment of high-risk acute leukemia with t-cell-depleted stem cells from related dono... |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2006-07-27 |
Journal Detail:
|
Title: Rheumatology international Volume: 27 ISSN: 0172-8172 ISO Abbreviation: Rheumatol. Int. Publication Date: 2006 Nov |
Date Detail:
|
Created Date: 2006-10-26 Completed Date: 2009-05-14 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8206885 Medline TA: Rheumatol Int Country: Germany |
Other Details:
|
Languages: eng Pagination: 97-100 Citation Subset: IM |
Affiliation:
|
Department of Pediatric Sciences, Center of Periodic Fevers, Università Cattolica Sacro Cuore, Rome, Italy. drigante@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antirheumatic Agents
/
therapeutic use* Child Dose-Response Relationship, Drug Familial Mediterranean Fever / drug therapy* Female Humans Interleukin 1 Receptor Antagonist Protein / therapeutic use* Mevalonate Kinase Deficiency / drug therapy* Receptors, Interleukin-1 / antagonists & inhibitors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antirheumatic Agents; 0/Interleukin 1 Receptor Antagonist Protein; 0/Receptors, Interleukin-1 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penic...
Next Document: Comparison of splinting, splinting plus local steroid injection and open carpal tunnel release outco...